Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

ETOFYLLINE CRS (20 MG)

ETOFYLLINE CRS (20 MG)

519-37-9

DISCOVER
ETOMIDATE CRS (50 MG)

ETOMIDATE CRS (50 MG)

33125-97-2

DISCOVER
ETOMIDATE IMPURITY B CRS (25 MG)

ETOMIDATE IMPURITY B CRS (25 MG)

5377-20-8

DISCOVER
ETOPOSIDE CRS (150 MG)

ETOPOSIDE CRS (150 MG)

33419-42-0

DISCOVER
Etoricoxib

Etoricoxib

202409-33-4

DISCOVER
Ethopabate

Ethopabate

59-06-3

DISCOVER
Eplerenone

Eplerenone

107724-20-9

DISCOVER
Entecavir

Entecavir

142217-69-4

DISCOVER
Erythromycin-13C D3

Erythromycin-13C D3

959119-26-7

DISCOVER
EUGENOL CRS (1 ML)

EUGENOL CRS (1 ML)

97-53-0

DISCOVER
(±)-Epinephrine-2,5,6,alpha,beta,beta D6

(±)-Epinephrine-2,5,6,alpha,beta,beta D6

1219803-77-6

DISCOVER
(1S,2S)-(+)-Pseudoephedrine D3 HCl (N-Me D3)

(1S,2S)-(+)-Pseudoephedrine D3 HCl (N-Me D3)

284665-25-4

DISCOVER